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Abbreviations 
ANS =Autonomic nervous system 
CHD = Coronary heart disease 
CR =  Cardiac rehabilitation 
CRET = Cardiac rehabilitation and exercise training 
CRF = Cardiorespiratory fitness 
CVD = Cardiovascular disease 
ET = Exercise training 
HF = Heart failure 
PA   = Physical  activity 
PS =Psychosocial stress 
SMT = Stress management training 
VO2  =  Oxygen consumption 
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Abstract 
 
The role of psychological risk factors has been under-recognized in most subspecialties of 
medicine, as well as in general medicine practices.  However, considerable evidence indicates 
that psychosocial factors are involved in the pathogenesis and progression of cardiovascular 
disease (CVD).  Emerging data from cardiac rehabilitation (CR) settings and CR-based exercise 
training (CRET) programs have demonstrated the value of comprehensive CR and exercise 
training to improve psychological functioning and reduce all-cause mortality.  Recent evidence 
also supports the  role of CRET and the added value of stress management training in the 
secondary prevention of CVD.   
 
Summary for Online Listing 
 
Psychological risk factors are involved in the pathogenesis of cardiovascular diseases (CVD) and 
impact prognosis in patients with CVD. Cardiac Rehabilitation and Exercise Training (CRET) 
programs lead to significant improvements in CVD risk factors, particularly improving levels  of 
cardiorespiratory fitness, and psychological risk factors and stress-related increased mortality 
risk. Efforts are needed to increase awareness of the impact of psychological stress in CVD and 
to increase referral and delivery of CRET. 
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There is considerable evidence that psychosocial stress (PS) plays an important role in the 
pathogenesis and progression of cardiovascular disease (CVD).1-3  Despite the widespread belief 
by lay people that PS worsens many medical conditions, including CVD, we believe that the 
importance of stress has been unrecognized or under appreciated by the medical community, 
especially among practioners  in CVD.1-4  PS is one of the most frequent complaints from 
patients, and PS adversely impacts numerous important medical conditions, including most 
chronic diseases (cancer, diabetes mellitus, arthritis, lung disease, human immunodeficiency 
virus), as well as CVD.1-6   Certainly, the link between PS and CVD is becoming increasingly 
better established. 1-6    
 
Cardiac rehabilitation and exercise training ( ET ;CRET) programs are an integral part of 
providing optimal medical therapy to patients with established coronary heart disease (CHD).7-9  
Substantial data from CRET programs have demonstrated dramatic improvements in exercise 
capacity or cardiorespiratory fitness (CRF), various CHD risk factors (lipids, glucose, blood 
pressure, inflammation), as well as measures of PS and quality of life .7,8  Although no single 
study has demonstrated major reductions in morbidity and mortality, with few exceptions, most 
major meta-analyses  over the past 3 decades have demonstrated reductions in morbidity and 
mortality.9,10 
 
In this select review of the area, we discuss the role of PS to impact CVD, the high prevalence of 
PS in patients with CVD, especially CHD, and the impact of CRET to reduce PS and PS-
associated mortality risk.  Finally, we review recent evidence on the potential importance of 
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stress management training (SMT) to further reduce PS and major clinical end-points when 
added to routine CRET programs. 
 
Does Psychological Stress Increase Cardiovascular Disease Risk? 
 
We believe thatthe topic of PS has been under-recognized by clinicians in most medical 
specialties, especially specialties in CVD.1-6  However, the lay public has been extremely 
interested in this topic in general and on the impact of PS on CVD. 4  Over the past 2 decades, the 
link between PS and CVD has become increasingly well-established.1-6 
 
Epidemiological data and prospective studies have explored the complex relationship between 
PS and CVD.1-6  When PS has been assessed by validated screening instruments, the clinical 
impact of PS has been comparable with many of the major CHD risk factors, including smoking, 
hypertension  and low physical activity (PA).1-6  Although most of the literature in PS has 
focused on depression and CVD, there is substantial evidence that other components of PS, 
including anxiety, hostility, isolation, strong adverse emotions, time urgency, and total PS, have 
significant impact on acute and chronic aspects of CVD.1  Certainly there is substantial evidence 
that PS plays an important role in the pathogenesis of CVD and on recovery following major 
CVD events (Figure 1).5  Indeed, PS disturbs cardiometabolic function, which may result in 
insulin resistance, HTN, inflammation, hyperglycemia and other metabolic disorders that may 
worsen endothelial dysfunction, which is a common denominator in CVD.  Also, practical issues 
may be involved, such as patients with greater PS engage in maladaptive, health-damaging 
behaviors, such as nonadherence with various aspects of the medical regimen, including 
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nonpharmacologic and drug treatment regimens, poor health habits, as well as substance 
abuse.5,11 
 
Arguably the most important epidemiologic data on the critical role of PS and CHD comes from 
the INTERHEART study,12 which evaluated major CHD risk factors and PS among a diverse 
group of 11,119 myocardial infarction patients and 13,648 age-and gender-matched control 
subjects from 52 countries and 262 centers.  This landmark study demonstrated that among 9 
major modifiable CHD risk factors, PS was third behind only lipids and smoking in importance, 
and PS accounted for close to 1/3 the total attributable risk for acute infarction.  In addition, 
epidemiological and laboratory studies have demonstrated that mental stress may provoke 
myocardial ischemia in the laboratory and during daily life, and mental stress-induced 
myocardial ischemia is associated with worse prognosis, over and above exercise testing. 5,13,14 
 
Potential reasons for these findings are numerous, but particularly important is that the 
autonomic nervous system (ANS) probably plays a significant role in mediating the effects of PS 
and CVD.11,15,16  Chronic imbalance of the ANS, with a shift toward higher sympathetic as 
opposed to parasympathetic/vagal tone, may worsen CVD prognosis.  In fact, over activation of 
the sympathetic nervous system may worsen endothelial function and coronary artery tone and 
predispose to various rhythm disorders, platelet activation and thrombosis, as well as elevated 
blood pressure and left ventricular hypertrophy, whereas parasympathetic activation or 
withdrawal has benefiscial and adverse effects on CVD,respectively  Many forms of PS will alter 
the balance between sympathetic to vagal tone, which clinically may be manifest as reduced 
heart rate variability , increased resting heart rate, blunted exercise heart rate and delayed heart 
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rate recovery following exercise, all evidence of ANS dysfunction that may increase the risk of 
CVD events. 
 
PS and CVD 
 
Although there are many aspects of PS which may worsen CVD, our research has largely 
focused on anxiety, hostility (or un-expressed anger) and depression in CHD. 
 
Anxiety and CVD.  Although probably less established than is the relationship of depression 
with CVD, a causal relationship has been suggested between anxiety and CVD.1,17,18  Several 
studies have suggested that anxiety may be an independent predictor of CHD morbidity and 
mortality.1,5,19,20  Elevated anxiety symptoms have been shown to be associated with a 2-fold 
increased risk of mortality in patients who have had coronary artery bypass graft surgery  21,22 
and in outpatients with CHD. 23,24  Frasure-Smith and colleagues25 reported that CHD patients 
with generalized anxiety disorder assessed two months following hospital discharge showed a 
2.3-fold increased risk of adverse CVD events, and Strik et al. 26reported a 2.8-fold increased risk 
of adverse events in acute post-infarct patients in which anxiety was measured one month 
following hospital discharge.  Similarly, a 2-fold increased risk of adverse events was observed 
in stable CHD patients23 and in patients with elevated anxiety during annual clinic visits.27  
Elevated anxiety symptoms in the coronary care unit are associated with increased mortality 
within the first years post-acute infarction. 28.  Anxiety appears to be prevalent among patients 
with CVD, perhaps more so in the younger CHD patients (Figure 2).18 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
Type A Behavior, Hostility and CVD.  Friedman and Rosenman29 first defined persons who 
exhibited an emotional syndrome characterized by a continuously harrying sense of time 
urgency, aggressiveness, ambitiousness, competitive drive, and easily aroused-free floating 
hostility as having type A behavior pattern.  Hostility, or cynical attitudes and distrust, as well 
and feeling of anger, have been linked to dyslipidemia, hypertension, inflammation, obesity, and 
atherosclerosis.1,30-34  Epidemiologic studies indicate that hostility has been linked to up to 5-fold 
increased risk of major CHD events.1,35-37  As with anxiety, younger patients have a much higher 
prevalence of hostility than do older CHD patients (Figure 2).18   
 
Depression and CVD.  Probably the strongest evidence for the link between PS and CVD comes 
from the data on depression in CVD and CHD.  In fact, numerous population studies have 
demonstrated highly statistically significant correlation between depression and increased risk of 
future CHD events.1-6  Prevalence rates of major depressive disorder among patients with CHD 
have been estimated to be as high as 25%, with point prevalence rates estimated at up to 45% for 
patients with minor depression or elevated depressive symptoms.38  Depression also has been 
associated with more than a 2-fold increased risk for patients undergoing  bypass surgery.39 In 
one meta-analysis of 20 prospective studies of patients with CHD, depressive symptoms were 
associated with an odds ratio of 2.24 for mortality.40  The American Heart Association recently 
recognized depression as a risk factor for patients with CHD, and encouraged routine assessment 
of depressive symptoms.41  Additionally, Grace and colleagues42 demonstrate that depression at 
the time of CVD hospitalization not only impacted quality  of life but also subsequent mortality.  
A sense of hopelessness, particularly, seems to be strongly correlated with adverse CVD 
outcomes.  Major studies have demonstrated a very high prevalence of depression among CHD 
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patients, probably moreso in women,43 and slightly moreso in younger as opposed to older CHD 
patients,18 although older patients have much higher prevalence of depression than anxiety or 
hostility (Figure 2).  Patients with diabetes seem to particularly have a high prevalence of 
depression.44,45 
 
Impact of CRET on PS 
 
We and others have demonstrated the powerful effects of CRET and improvements in CRF on 
PS and PS-induced mortality. 
 
Role of CRET in Anxiety.  Patients with CHD, especially younger patients, have a very high 
prevalence of anxiety (Figure 2).18  Following formal CRET, the prevalence of anxiety (Kellner 
Anxiety Score > 7) and high anxiety (Kellner Anxiety Score > 10) fell by 56% and 69%, 
respectively in one study,17 and then in another study fell by 61% in younger patients and by 
32% in older CHD patients (Table 1).18  A meta-analysis mostly from CVD cohorts also 
demonstrated that ET significantly reduced anxiety symptoms.46 
 
Role of CRET in Hostility.  Over fifteen years ago, we demonstrated that following CRET, 
hostility, which is often defined as unexpressed anger and defined in our study as Kellner 
Hostility Score > 7,  fell from 28% at baseline to 15% in young patients and from 8% to only 4% 
in those older than 65 years.47  In a more recent study (Figure 2, Table 1),18 we demonstrated 
greater than 50% reductions in the prevalence of hostility in both younger and older CHD 
patients.   
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Impact of CRET on Depressive Symptoms.  Probably the most powerful evidence of the role of 
CRET in secondary CHD prevention is in patients with depression.  Although depressive 
symptoms seem to be prevalent in CHD patients regardless of age, the prevalence of depressive 
symptoms ( Kellner Depression Score > 6) seems to be especially high in CHD patients with 
diabetes 44,45 and in women.43  However, following formal CRET programs, the prevalence of 
depression generally is reduced by over 50%.18   
 
Especially noteworthy is the impact of CRET to reduce not only depressive symptoms but 
depression-related increased mortality.  In a study of 522 consecutive CHD patients enrolled in 
CRET and in 179 CHD patients who did not complete CRET, we assessed the impact of 
depressive symptoms on subsequent survival.48  Following CRET, the prevalence of depressive 
symptoms fell from 17% to only 6% (minus 63%; p<0.001).  Moreover, depressive symptoms in 
CHD patients following CRET had a 4-fold higher mortality than did non-depressed patients, 
and in those with baseline depressive symptoms who completed CRET, mortality was 73% lower 
compared with depressed patients who did not participate in formal CRET programs (8% versus 
30%; p=0.005).  Since CRET involves more than just ET intervention, as discussed in detail in 
this Symposium, we assessed changes in CRF and subsequent risk of depression and mortality.  
Using cardiopulmonary gas exchange to precisely assess CRF before and after CRET, we 
demonstrated that those who did not improve their peak oxygen consumption (peak VO2) 
continued to have a high prevalence of depressive symptoms and high mortality risk during 
follow-up (Figure 3).48  However, those who either had small improvements or more marked 
improvements in peak VO2 both had striking reductions in the prevalence of depressive 
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symptoms and depression-related increased mortality risk. In a randomized control trial of 101 
CHD patients, ET and sertraline therapy both resulted in greater reductions in depressive 
symptoms and improvements in heart rate variability compared with placebo, although there 
appeared to be a trend to greater benefit  with ET than with sertraline (p=0.09). 49 
 
 The HF :ACTION was a large randomized trial of ET versus usual care in 2,322 patients with 
systolic  heart failure (HF ) and demonstrated significant benefits of ET over usual care in both 
reducing depression symptoms and clinical events,  despite only inducing a mean improvement 
in peak VO2 of 4 %.50  We also assessed the impact of CRET on depression and survival in CHD 
patients with systolic HF.51  Similar to non-HF patients with CHD, depression fell from 22% to 
13% following CRET (- 40%; p<0.001).  Those who were initially depressed and who remained 
depressed following CRET had a 4-fold higher mortality than did HF patients whose depression 
resolved with CRET (43% versus 11%; p=0.005).  Additionally, HF patients who completed 
CRET had considerably lower mortality than did HF patients who did not complete CRET (18% 
versus 44%; - 59%; p<0.005).  As with non-HF patients, the survival benefits following CRET 
are mostly noted in depressed HF patients who significantly improved peak VO2 following 
CRET (Figure 4).51 
 
Benefits of CRET on Total PS.  We previously assessed 500 consecutive CHD patients and 
demonstrated that improvements following CRET were similar or even greater in those with high 
as opposed to low PS ( based on combined Kellner scores for depression, anxiety, hostility , and 
somatization.)52  In another study, we combined Kellner scores for anxiety, hostility and 
depression for a total PS score, which predicted mortality in 522 consecutive CHD patients.53  In 
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fact, almost all of the mortality during follow-up was noted in those with high PS who did not 
improve CRF (defined as <10% improvement in peak VO2 following CRET).  On the other 
hand, patients with low PS at baseline and those with high PS who significantly improved their 
peak VO2 by at least 10% had low 3-year mortality (Figure 5).53 
 
Finally, in a study of 538 who completed CRET, we assessed whether other PS contributed to 
mortality risk.54  Following CRET, we compared mortality in 502 non-depressed patients with 
mortality in 14 patients with depressive symptoms alone and 22 patients with depressive 
symptoms combined with anxiety and/or hostility symptoms.  Although there was a trend of 
higher mortality in the comorbid depression group compared with depression alone (23% versus 
14%; p=NS), the overall impact was largely driven by depressive symptoms (19% mortality 
versus 3% in non-depressed patients; p<0.001).  This study was limited, however, by the fairly 
low prevalence of PS following formal CRET. 
 
Addition of Stress Management Training to Routine CRET 
In a series of studies of patients with mental-stress induced myocardial ischemia, Blumenthal and 
colleagues reported  that patients randomized to either SMT or ET had better clinical outcomes 
compared to non-randomized usual care controls.55  Moreover, SMT and ET produced 
complementary benefits:  SMT reduced mental stress-induced ischemia while ET reduced 
exercise-induced ischemia.  In a subsequent, fully randomized trial,  SMT and ET each produced 
comparable improvements in psychological functioning as well as greater improvements in 
biomarkers of CVD risk compared to usual care controls.56  While these studies compared ET to 
SMT, more recently, Blumenthal and colleagues57 examined the combined benefit of ET and 
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SMT.  In the ENHANCED trial,  151 CHD patients were randomized to standard CRET or 
comprehensive CRET combined with SMT;  a matched group of CRET-eligible patients who did 
not attend CRET comprised a comparison group.  During follow-up of 5.3 years (median 3.2 
years), patients randomized to SMT, consisting of combined education, group support and 
cognitive behavior therapy delivered in 12 weekly 1.5 hour sessions in groups of 4-8 
participants, exhibited greater reductions in composite PS levels compared with CRET alone 
(p=0.022), an effect that was driven primarily by reductions in anxiety, distress and perceived 
stress.  Both CRET groups had lower composite clinical event rates compared with the non-
CRET comparison group (hazard ratio/HR 0.44; confidence interval/CI 0.27-0.71; p<0.001) but 
CRET +SMT had lower clinical events than did CRET alone (18% versus 33%; HR 0.49; CI 
0.25 – 0.95; p=0.04), suggesting additional benefit for adding SMT to routine CRET therapy to 
enhance secondary prevention of CHD (Figure 6).57 
 
Interestingly not all studies have found SMT to improve clinical outcomes.  In a study of 2,328 
post-infarction patients randomized to 7 weekly sessions of SMT or usual care and followed for 
12 months, Jones and West58 reported that prevalence rates of anxiety and depression remained 
high and there were no important group differences following treatment and no differences in 
major clinical end-points.  In 1,376 post-MI patients, Frasure-Smith and colleagues59 randomized 
patients to telephone-based SMT versus usual care, and also found no group differences in PS or 
clinical outcomes during follow-up.  The ENRICHD trial60 studied 2400 post MI patients with 
depression or who reported low social support and assessed the impact of cognitive-behavior 
therapy versus usual care.  Although the intervention group demonstrated modest 2 point 
differences in the Beck Depression Inventory compared with usual care, there were also no 
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significant impacts noted on major clinical events.  In contrast, the most recent study by 
Blumenthal and colleagues57 compared SMT/CRET  with CRET alone and demonstrated 
additional effects of SMT when combined with the already well-proven effects of ET-based 
formal CRET intervention. These data suggest that the combination of SMT and CRET is 
especially effective. Further studies are needed to determine whether SMT can be combined with 
new models of CRET, which are needed to enhance the delivery and effectiveness of CRET 
programs in the modern era.9 
 
Potential Mechanisms for PS Benefits 
 
The mechanism by which behavioral factors and PS contribute to CVD and CHD is not 
completely understood but likely multifactorial, including worsening CHD risk factors which 
contribute to atherosclerosis, adverse effects on the ANS, inflammation, enhanced platelet 
activation, circulating catecholamines, cortisol, reduced myocardial ischemia, and enhanced 
coronary vasoreactivity and constriction.1,18-18,30,48  Likewise, an improvement in risk factors and 
PS following CRET is also probably multifaceted.  Certainly, the CRET programs are centered 
around increasing PA and ET to improve CRF, which correlates with most of the improvements 
and prognosis with CRET therapy in general and for PS.  However, CRET also has beneficial 
effects on certain emotions and improving ANS function,16 and improves inflammation,61,62 
metabolic syndrome63,64 and blood rheology.65  Some evidence suggests that ET also has 
favorable effects on brain plasticity and cognition. 66,67 In fact, CRET involves more than just 
ET, and other aspects of the Phase II CRET programs involve education of the patients and their 
significant others, which may also be important by increasing understanding of the underlying 
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disease process and its manifestations, therefore "empowering" patients to modify their own 
recovery, which is a process called "information involvement," which may also enhance coping 
mechanisms as well as emotional and social recovery processes.66,67  In addition, CRET 
programs have aspects of "group therapy," that is often used by psychologists and psychiatrists 
that may promote socialization and bonding with other patients in CRET who are at various 
stages in their recovery process.66,68  Despite the significant improvements in PS following 
CRET, many patients continue to experience PS following CRET and have high morbidity and 
mortality.  Further therapy directed at PS, including behavior modification, psychotherapy, 
and/or pharmacologic intervention could be required.66,69,70  The recent data with SMT seems 
particularly attractive for  improving the already substantial improvements noted with CRET.57  
Limitations 
 
Several limitations of the studies discussed in this paper should also be noted.  Many of the 
Ochsner studies were not randomized, which raises the possibility of non-specific effects, 
regression to the mean or  selection bias.  However, since CRET programs are well established 
around the world7-9,71-73 it is difficult  to randomize patients to no CRET therapy in which they 
would be denied what is now considered the standard of care for patients with CVD.  Also, much 
of the data that we presented comes from a single center ( Ochsner Medical Center in New 
Orleans,LA) with a strong clinical and research emphasis on CRET and PS, so other CRET 
investigators also need to evaluate the impact of CRET and unique CRET delivery systems on 
psychological risk factors and subsequent prognosis. 
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Conclusion 
Substantial evidence suggests that PS has adverse effects on the pathogenesis and progression of 
CVD and adversely impacts prognosis following major CHD events.  Although most of the 
evidence has focused on the role of depression in CVD, other aspects of PS, including anxiety, 
hostility, and total PS, also may impact prognosis in CVD.  Following formal CRET programs, 
substantial evidence indicates that CRET markedly reduces PS and PS-related increased 
mortality rates.  Recent evidence suggests that the benefits of CRET may be further enhanced 
with the addition of SMT to patients receiving CRET intervention. Other RET investigators 
need to also evaluate the impact of CRET and unique CRET delivery systems on psychological 
risk factors and subsequent prognosis. Finally, considerably greater emphasis is needed on PS 
and its intervention, especially with CRET, in the secondary prevention of CVD and, especially, 
CHD. 
 
It is exercise alone that supports the spirit, and keeps the mind in vigor. – Cicero74 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
17 
 
References 
 
1. Lavie CJ, Milani RV, O’Keefe JH, Lavie TJ.  Impact of exercise training on 
psychological risk factors.  Prog Cardiovasc Dis 2011;53:464-470. 
2. Menezes AR, Lavie CJ, Milani RV, O’Keefe JH, Lavie TJ.  Psychological risk factors 
and cardiovascular disease:  is it all in your head?  Postgrad Med 2011;123:165-176.   
3. Lavie CJ, Milani RV, Artham SM, Gilliland Y.  Psychological factors and cardiac risk 
and impact of exercise training programs-a review of Ochsner studies.  Ochsner J 
2007;7:167-172.   
4. Dimsdale JE: Psychological stress and cardiovascular disease.  J Am Coll Cardiol 
2008;51:1237-1246. 
5. Rozanski A, Blumental JA, Davidson KW, et al.  The epidemiology, pathophysiology, 
and management of psychosocial risk factors in cardiac practice: the emerging field of 
behavioral cardiology.  J Am Coll Cardiol 2005;45:637-651. 
6. Figueredo VM.  The time has come for physicians to take notice: the impact of 
psychosocial stressors on the heart.  Am J Med 2009 122:704-712. 
7. Menezes AR, Lavie CJ, Milani RV, Forman DE, King M, Williams MA.  Cardiac 
rehabilitation in the United States.  Prog Cardiovasc Dis 2014;56:533-529. 
8. Menezes AR, Lavie CJ, Forman DE, Arena R, Milani RV, Franklin BA.  Cardiac 
rehabilitation in the elderly.  Prog Cardiovasc Dis 2014;57:152-159.   
9. Lavie CJ, Arena R, Franklin BA.  Cardiac rehabilitation and healthy life-style 
interventions:  rectifying program deficiencies to improve patient outcomes.  J Am Coll 
Cardiol 2016;67:13-15.   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
10. Anderson L, Oldridge N, Thompson DR, et al.  Exercise-based cardiac rehabilitation for 
coronary heart disease:  Cochrane systematic review and meta-analysis.   J Am Coll 
Cardiol 2016;67:1-12. 
11. Das S, O’Keefe JH.  Behavioral cardiology: recognizing and addressing the profound 
impact of psychosocial stress on cardiovascular health.  Curr Atheroscler Rep 
2006;8:111-118.    
12. Rosengren A, Hawken S, Ounpuu S, et al.  Association of psychosocial risk factors with 
risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries 
(the INTERHEART study): case-control study.  Lancet 2004;364:953-962. 
13. Blumenthal JA, Jiang W, Waugh RA, et al.  Mental stress-induced ischemia in the 
laboratory and ambulatory ischemia during daily life: association and hemodynamic 
features.  Circulation 1995;92:2102-2108. 
14. Jiang W, Babyak M, Krantz DS, et al.  Mental stress-induced myocardial ischemia and 
cardiac events.  JAMA 1996;275:1651-1656. 
15. Lavie CJ, Milani RV.  Depression, autonomic function, and cardiorespiratory fitness:  
comments on Hughes, et al. (2010). Percept Mot Skills 2011;112:319-321.   
16. Lucini D, Milani RV, Costantino G, et al.  Effects of cardiac rehabilitation and exercise 
training on autonomic regulation in patients with coronary artery disease.  Am Heart J 
2002;143:977-983. 
17. Lavie CJ, Milani RV.  Prevalence of anxiety in coronary patients with improvement 
following cardiac rehabilitation and exercise training.  Am J Cardiol 2004;93:336-339. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
18. Lavie CJ, Milani RV.  Adverse psychological and coronary risk profiles in young patients 
with coronary artery disease and benefits of formal cardiac rehabilitation.  Arch Intern 
Med 2006;166:1878-1883. 
19. Kawachi I, Colditz GA, Ascherio A, et al.  Prospective study of phobic anxiety and risk 
of coronary heart disease in men. Circulation 1994;89:1992–1997. 
20. Kawachi I, Sparrow D, Vokonas PS, et al.  Symptoms of anxiety and risk of coronary 
heart disease.  The Normative Aging Study. Circulation 1994;90:2225–2229. 
21. Tully PJ, Baker RA, Knight JL. Anxiety and depression as risk factors for mortality after 
coronary artery bypass surgery.  J Psychosom Res 2008;64:285-290. 
22. Szekely A, Balog P, Benko E, et al.  Anxiety predicts mortality and morbidity after 
coronary artery and valve surgery:  a 4-year follow-up study.  Psychosom Med 
2007;69:625-631. 
23. Frasure-Smith N, Lesperance F.  Depression and anxiety as predictors of 2-year cardiac 
events in patients with stable coronary artery disease.  Arch Gen Psychiatry 2008;65:62-
71. 
24. Rothenbacher D, Hahmann H, Wusten B, Koenig W, Brenner H.  Symptoms of anxiety 
and depression in patients with stable coronary heart disease: prognostic value and 
consideration of pathogenetic links.  Eur J Cardiovasc Prev Rehabil 2007;14:547-554. 
25. Frasure-Smith N.  In-hospital symptoms of psychological stress as predictors of long-
term outcome after acute myocardial infarction in men.  Am J Cardiol 1991;67:121-127. 
26. Strik JJ, Denollet J, Lousberg R, Honig A.  Comparing symptoms of depression and 
anxiety as predictors of cardiac events and increased health care consumption after 
myocardial infarction. J Am Coll Cardiol 2003;42:1801-1807. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
27. Shibeshi WA, Young-Xu Y, Blatt CM.  Anxiety worsens prognosis in patients with 
coronary artery disease. J Am Coll Cardiol 2007;49:2021-2027. 
28. Wrenn KC, Mostofsky E, Tofler GH, Muller JE, Mittleman MA.  Anxiety, anger, and 
mortality risk among survivors of myocardial infarction. Am J Med 2013;126:1107-1113. 
29. Friedman M, Rosenman RH.  Association of specific overt behavior pattern with blood 
and cardiovascular findings:  blood cholesterol level, blood clotting time, incidence of 
arcus senilis, and clinical coronary artery disease.  JAMA 1959;169:1286-1296. 
30. Lavie CJ, Milani RV.  Prevalence of hostility in young coronary artery disease patients 
and effects of cardiac rehabilitation and exercise training.  Mayo Clin Proc 2005;80:335-
342. 
31. Yan LL, Liu K, Matthews KA, et al.  Psychosocial factors and risk of hypertension:  the 
Coronary Artery Risk Development in Young Adults (CARDIA) study.  JAMA 
2003;290:2138-2148. 
32. Whiteman MC, Deary IJ, Fowkes FG.  Personality and social predictors of 
atherosclerotic progression: Edinburgh Artery Study. Psychosom Med 2000;62:703-714. 
33. Chida Y, Steptoe A.  The association of anger and hostility with future coronary heart 
disease:  a meta-analytic review of prospective evidence.  J Am Coll Cardiol 
2009;53:936-946. 
34. Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallet AJ.  A meta-analytic review of 
research on hostility and physical health.  Psychol Bull 1996;119:322-348. 
35. Rosenman RH, Brand RJ, Jenkins D, et al.  Coronary heart disease in Western 
Collaborative Group Study:  final follow-up experience of 8 1/2 years.  JAMA 
1975;233:872-877. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
36. Friedman M, Thoresen CE, Gill JJ, et al.  Alteration of type A behavior and its effect on 
cardiac recurrences in post myocardial infarction patients:  summary results of the 
recurrent coronary prevention project.  Am Heart J 1986;112:653-665. 
37. Barefoot JC, Dahlstrom WG, Williams Jr RB.  Hostility, CHD incidence, and total 
mortality:  a 25-year follow-up study of 255 physicians.  Psychosom Med 1983;45:59-63. 
38. Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary 
artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-315. 
39. Blumenthal JA, Lett HS, Babyak MA, et al; for NORG Investigators.  Depression as a 
risk factor for mortality after coronary artery bypass surgery.  Lancet 2003;362:604-609. 
40. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in 
patients with coronary heart disease: a meta-analysis. Psychosom Med 2004;66:802-13. 
41. Lichtman JH, Froelicher ES, Blumenthal JA, et al; for American Heart Association 
Statistics Committee of the Council on Epidemiology and Prevention and the Council on 
Cardiovascular and Stroke Nursing.  Depression as a risk factor for poor prognosis 
among patients with acute coronary syndrome:  systematic review and recommendations:  
a scientific statement from the American Heart Association.   Circulation 2014;129:1350-
1369.   
42. Grace SL, Abbey SE, Kapral MK, et al.  Effect of depression on five-year mortality after 
an acute coronary syndrome.  Am J Cardiol 2005;96:1179-1185. 
43. Lavie CJ, Milani RV, Cassidy MM, et al.  Effects of cardiac rehabilitation and exercise 
training programs in women with depression.  Am J Cardiol 1999;83:1480-1483. 
44. Lavie CJ, Milani RV.  Behavioral differences and effects of cardiac rehabilitation in 
diabetic patients following cardiac events.  Am J Med 1996;100:517-523.   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
22 
 
45. Lavie CJ, Milani RV.  Cardiac rehabilitation and exercise training programs in metabolic 
syndrome and diabetes.  J Cardiopulm Rehabil 2005;25:59-66. 
46. Herring MP, O’Connor PJ, Dishman RK.  The effect of exercise training on anxiety 
symptoms among patients.  Arch Intern Med 2010;170:321-331.   
47. Lavie CJ, Milani RV.  Effects of cardiac rehabilitation and exercise training programs on 
coronary patients with high levels of hostility.  Mayo Clin Proc 1999;74:959-966. 
48. Milani RV, Lavie CJ.  Impact of cardiac rehabilitation on depression and its associated 
mortality.  Am J Med 2007;120:799-806. 
49. Blumenthal JA, Sherwood A, Babyak MA, et al.  Exercise and pharmacological treatment 
of depressive symptoms in patients with coronary heart disease:  results from the 
UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant 
Therapy) study.  J Am Coll Cardiol 2012;60:1053-1063. 
50. Blumenthal JA, Babyak MA, O’Connor C, et al.  Effects of exercise training on 
depressive symptoms in patients with chronic heart failure:  the HF-ACTION randomized 
trial.  JAMA 2012;308:465-474. 
51. Milani RV, Lavie CJ, Mehra MR, et al.  Impact of exercise training and depression on 
survival in heart failure due to coronary heart disease.  Am J Cardiol 2011;107:64-68.   
52. Artham SM, Lavie CJ, Milani RV.  Cardiac rehabilitation programs markedly improve 
high-risk profiles in coronary patients with high psychological distress.  South Med J 
2008;101:262-267.   
53. Milani, RV, Lavie CJ.  Reducing psychosocial stress: a novel mechanism of improving 
survival from exercise training.  Am J Med 2009;122:931-938. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
23 
 
54. De Schutter A, Lavie CJ, Milani RV.  Relative importance of comorbid psychological 
symptoms in patients with depressive symptoms following phase II cardiac rehabilitation.  
Postgrad Med 2011;12372-78. 
55. Blumenthal JA, Jiang W, Babyak MA, et al. Stress management and exercise training in 
cardiac patients with myocardial ischemia.  Effects on prognosis and evaluation of 
mechanisms. Arch Intern Med 1997;157:2213-2223. 
56. Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of exercise and stress 
management training on markers of cardiovascular risk in patients with ischemic heart 
disease: A randomized controlled trial.  JAMA 2005;293:1626-1634. 
57. Blumenthal JA, Sherwood A, Smith PJ, et al.  Enhancing cardiac rehabilitation with 
stress management training:  a randomized clinical efficacy trial.  Circulation 
2016;133:1341-50. 
58. Jones DA, West RR.  Psychological rehabilitation after myocardial infarction: 
multicentre randomised controlled trial.  BMJ 1996;313:1517–1521. 
59. Frasure-Smith N, Lespérance F, Prince RH, et al. Randomised trial of home-based 
psychosocial nursing intervention for patients recovering from myocardial infarction.  
Lancet 1997;350:473–479. 
60. Berkman LF, Blumenthal J, Burg M, et al.  Enhancing Recovery in Coronary Heart 
Disease Patients Investigators (ENRICHD).  Effects of treating depression and low 
perceived social support on clinical events after myocardial infarction:  the Enhancing 
Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.  JAMA 
2003;289:3106–3116. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
24 
 
61. Milani RV, Lavie CJ, Mehra MR.  Reduction in C-reactive protein through cardiac 
rehabilitation and exercise training.  J Am Coll Cardiol 2004;43:1056-1061. 
62. Lavie CJ, Church TS, Milani RV, et al.  Impact of physical activity, cardiorespiratory 
fitness, and exercise training on markers of inflammation.  J Cardiopulm Rehabil Prev 
2011;31:137-45. 
63. Lavie CJ, Milani RV.  Cardiac rehabilitation and exercise training programs in metabolic 
syndrome and diabetes.  J Cardiopulm Rehabil 2005;25:59-66. 
64. Milani RV, Lavie CJ.  Prevalence and profile of metabolic syndrome in patients 
following acute coronary events and effects of therapeutic lifestyle change with cardiac 
rehabilitation.  Am J Cardiol 2003;92:50-54. 
65. Church TS, Lavie CJ, Milani RV, et al.  Improvements in blood rheology after cardiac 
rehabilitation and exercise training in patients with coronary heart disease.  Am Heart J 
2002;143:349-355. 
66. Lavie CJ, Milani RV, Lavie TJ.  Impact of cardiac rehabilitation, exercise training, and 
fitness on psychological distress.  In:  Sher L, (ed):  Psychological Factors and 
Cardiovascular Disorders: The Role of Psychiatric Pathology & Maladaptive Personality 
Features.  Hauppauge, NY:  Nova Science Publishers, 2009: 312-329. 
67. Krantz DS, Baum A, Wideman M.  Assessment of preferences for self-treatment and 
information in health care.  J Pers Soc Psychol 1980;39:977-990.   
68. Kulik JA, Mahler HI.  Social support and recovery from surgery.  Health Psychol 
1989;8:221-238. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
25 
 
69. Hamer M, Molloy GJ, Stamatakis E.  Psychological distress as a risk factor for 
cardiovascular events:  pathophysiological and behavioral mechanisms.  J Am Coll 
Cardiol 2008;52:2156-2162.   
70. Carney RM, Freeland KE.  Treatment-resistant depression and mortality after acute 
coronary syndrome.  Am J Psychiatry 2009;166:410-417. 
71. Grace SL, Bennett S, Ardern CI, Clark AM.  Cardiac rehabilitation series:  Canada.  Prog 
Cardiovasc Dis 2014;56:530-535.   
72. Humphrey R, Guazzi M, Niebauer J.  Cardiac rehabilitation in Europe.  Prog Cardiovasc 
Dis 2014;56:551-556.   
73. Madan K, Babu AS, Contractor A, Sawhney JP, Prabhakaran D, Gupta R.  Cardiac 
rehabilitation in India.  Prog Cardiovasc Dis 2014;56:543-550.   
74. Cicero:  On Old Age.  Vol 9. Part 2. The Harvard Classics.  Shuckburgh ES, trans-ed.  
New York, NY:  PF Collier and Son; 1909-14, p 10. 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
26 
 
Figure Legend 
 
1. Several reasons for interest by medical practices in the evaluation and treatment of 
psychosocial stress.  CHD  =  coronary heart disease.  Reproduced with permission from 
Rozanski A et al.5 
2. Prevalence of adverse behavioral characteristics in young (mean ± SD, 48 ± 6 years) and 
older (mean ± SD, 75 ± 3 years) patients with CHD.  Reproduced with permission from 
Lavie CJ et al.18 
3. Prevalence of depression and subsequent mortality based on changes in peak VO2 during 
cardiac rehabilitation and ET.  *P <.001 compared with VO2 loss.  Reproduced with 
permission from Milani RV et al.48 
4. Actuarial hazard for death comparing patients with HF with and without depression 
stratified by change in oxygen uptake after ET (p <0.01 between oxygen uptake 
loss/depressed and all others).  Reproduced with permission from Milian RV et al.51 
5. Actuarial cumulative hazard plot for survival time based on changes in exercise capacity 
(high exercise change vs low exercise change) after ET split by baseline psychosocial 
stress (high psychosocial stress vs low psychosocial stress; n = 522).  Reproduced with 
permission from Milani RV et al.53  
6. Cumulative time-to-event curves for clinical events in the CR+SMT, CR-alone, and No-
CR groups. Clinical events included all-cause mortality, myocardial infarction, cardiac or 
peripheral vascular intervention, stroke/TIA, or unstable angina requiring hospitalization.  
Participants in the CR+SMT were at significantly lower risk of clinical events compared 
with the CR-alone group (HR= 0.47 [0.24, 0.91], P = 0.025). Both CR groups had lower 
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event rates compared with a non-randomized, matched No-CR control group (HR = 0.35 
[0.22, 0.56], P <.001). Number at risk represents participants with follow-up data for 
clinical events who had not yet had an event at years 0, 2, and 4.  Reproduced with 
permission from Blumenthal JA et al.57 
 
 
 
 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
28 
 
Table 1.  Effects of Cardiac Rehabilitation and ET Programs on Symptoms of Anxiety, 
Hostility, and Depression in Young and Older Patients with Coronary Artery Disease.   
 
  
Young Patients (n = 104) 
 
Older Patients (n = 260) 
Symptom Before 
Rehabilitation 
 % 
After 
Rehabilitation 
% 
P  
Value 
Before 
Rehabilitation 
% 
After 
Rehabilitation 
% 
P  
Value 
 
Anxiety 
 
27.9 
 
8.7 
 
<.001 
 
13.5 
 
9.2 
 
<.01 
 
Hostility 
 
12.5 
 
5.8 
 
<.01 
 
4.6 
 
2.3 
 
<.05 
 
Depression 
 
23.1 
 
3.8 
 
<.001 
 
18.8 
 
6.2 
 
<.001 
 
 
 
Data adapted from Lavie et al,18 reproduced with permission from Lavie et al.1 
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